The patient-2 tumor sample yielded 453 total cells, with 208 (46%) identified as HGSOC cells, from which we identified 17 different malignant cell enriched fusion transcripts (Supplemental Table S7), including the earlier-identified IGF2BP2::TESPA1 fusion between Chr 3 and Chr 12 evident in 176/208 (85%) of the tumor cells. This evidence concerns the gene IGF2BP2 and neoplasm.